• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清碱性磷酸酶浓度随时间变化与腹膜透析患者死亡率之间的关系:一项为期五年的队列研究。

An association between time-varying serum alkaline phosphatase concentrations and mortality rate in patients undergoing peritoneal dialysis: a five-year cohort study.

机构信息

Department of Nephrology, Tianjin First Center Hospital, Tianjin, CO300192, China.

Department of Nephrology, Tianjin Union Medicine Center, Tianjin, CO300000, China.

出版信息

Sci Rep. 2017 Mar 3;7:43314. doi: 10.1038/srep43314.

DOI:10.1038/srep43314
PMID:28256582
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5335666/
Abstract

The relationship between serum alkaline phosphatase (ALP) concentrations and mortality in peritoneal dialysis (PD) patients is rarely reported. We enrolled 667 PD patients in one PD centre in Taiwan to retrospectively examine the association between three ALP concentrations (baseline, time-averaged, time-dependent) and mortality over a 5-year period (2011-2015). Baseline data collection included demographics, clinical, and laboratory parameters. Multivariable-adjusted Cox models were used to analyse the association. Four ALP quartiles were defined at the baseline: ≤62, 63-82, 83-118, and ≥119 U/L. Of 667 patients, 65 patients died, of which 8 patients died due to cardiovascular disease. Females were predominant in the higher ALP quartiles, and 24-h urine volume was significantly proportionately decreased in the higher ALP quartiles. ALP quartiles expressed by the three models were not associated with all-cause or cardiovascular mortalities after adjusting for demographics, liver function, bone metabolism, mortality, hemoglobin, and 24-h urine volume. In conclusion, ALP concentrations were not associated with death risk in PD patients over the 5-year period.

摘要

血清碱性磷酸酶(ALP)浓度与腹膜透析(PD)患者死亡率之间的关系很少有报道。我们在台湾的一个 PD 中心纳入了 667 例 PD 患者,回顾性分析了在 5 年期间(2011-2015 年)三种 ALP 浓度(基线、时间平均、时间依赖)与死亡率之间的关系。基线数据收集包括人口统计学、临床和实验室参数。采用多变量调整 Cox 模型分析相关性。在基线时将 ALP 分为四个四分位区间:≤62、63-82、83-118 和≥119U/L。667 例患者中有 65 例死亡,其中 8 例死于心血管疾病。女性在较高的 ALP 四分位数中占优势,较高的 ALP 四分位数组 24 小时尿量显著减少。在调整了人口统计学、肝功能、骨代谢、死亡率、血红蛋白和 24 小时尿量等因素后,三种模型表示的 ALP 四分位数与全因死亡率或心血管死亡率均无相关性。总之,在 5 年期间,ALP 浓度与 PD 患者的死亡风险无关。

相似文献

1
An association between time-varying serum alkaline phosphatase concentrations and mortality rate in patients undergoing peritoneal dialysis: a five-year cohort study.血清碱性磷酸酶浓度随时间变化与腹膜透析患者死亡率之间的关系:一项为期五年的队列研究。
Sci Rep. 2017 Mar 3;7:43314. doi: 10.1038/srep43314.
2
Comparative mortality-predictability using alkaline phosphatase and parathyroid hormone in patients on peritoneal dialysis and hemodialysis.使用碱性磷酸酶和甲状旁腺激素对腹膜透析和血液透析患者进行死亡率预测的比较
Perit Dial Int. 2014 Nov-Dec;34(7):732-48. doi: 10.3747/pdi.2013.00110. Epub 2014 Jan 2.
3
Alkaline phosphatase and mortality in patients on peritoneal dialysis.腹膜透析患者的碱性磷酸酶与死亡率
Clin J Am Soc Nephrol. 2014 Apr;9(4):771-8. doi: 10.2215/CJN.08280813. Epub 2014 Jan 23.
4
Serum Alkaline Phosphatase Levels Predict Infection-Related Mortality and Hospitalization in Peritoneal Dialysis Patients.血清碱性磷酸酶水平可预测腹膜透析患者的感染相关死亡率和住院率。
PLoS One. 2016 Jun 16;11(6):e0157361. doi: 10.1371/journal.pone.0157361. eCollection 2016.
5
Elevated serum alkaline phosphatase and cardiovascular or all-cause mortality risk in dialysis patients: A meta-analysis.血清碱性磷酸酶升高与透析患者心血管或全因死亡风险:一项荟萃分析。
Sci Rep. 2017 Oct 16;7(1):13224. doi: 10.1038/s41598-017-13387-z.
6
Outcome predictability of serum alkaline phosphatase in men with pre-dialysis CKD.男性透析前 CKD 患者血清碱性磷酸酶的预后预测性。
Nephrol Dial Transplant. 2010 Sep;25(9):3003-11. doi: 10.1093/ndt/gfq144. Epub 2010 Mar 17.
7
Serum alkaline phosphatase levels correlate with long-term mortality solely in peritoneal dialysis patients with residual renal function.血清碱性磷酸酶水平与残余肾功能的腹膜透析患者的长期死亡率相关。
Ren Fail. 2019 Nov;41(1):718-725. doi: 10.1080/0886022X.2019.1646662.
8
Serum Alkaline Phosphatase Levels are Not Associated with Increased Death Risk in Prevalent Hemodialysis Patients: 5-Year Experience in a Single Hemodialysis Center.血清碱性磷酸酶水平与维持性血液透析患者死亡风险增加无关:单中心血液透析中心5年经验
Kidney Blood Press Res. 2016;41(4):498-506. doi: 10.1159/000443451. Epub 2016 Jul 29.
9
Total and bone-specific alkaline phosphatase are associated with bone mineral density over time in end-stage renal disease patients starting dialysis.在开始透析的终末期肾病患者中,总碱性磷酸酶和骨特异性碱性磷酸酶随时间推移与骨矿物质密度相关。
J Nephrol. 2017 Apr;30(2):255-262. doi: 10.1007/s40620-016-0292-7. Epub 2016 Mar 18.
10
Roles of Serum Calcium, Phosphorus, PTH and ALP on Mortality in Peritoneal Dialysis Patients: A Nationwide, Population-based Longitudinal Study Using TWRDS 2005-2012.血清钙、磷、PTH 和 ALP 对腹膜透析患者死亡率的作用:使用 TWRDS 2005-2012 进行的全国性、基于人群的纵向研究。
Sci Rep. 2017 Feb 24;7(1):33. doi: 10.1038/s41598-017-00080-4.

引用本文的文献

1
Longitudinal study on the change trend of serum alkaline phosphatase and its possible influencing factors in peritoneal dialysis patients.腹膜透析患者血清碱性磷酸酶变化趋势及其可能影响因素的纵向研究。
Sci Rep. 2024 Jun 7;14(1):13099. doi: 10.1038/s41598-024-63721-5.
2
Associations between liver function parameters and poor clinical outcomes in peritoneal dialysis patients.肝功能参数与腹膜透析患者不良临床结局的关系。
Ther Apher Dial. 2023 Feb;27(1):12-18. doi: 10.1111/1744-9987.13926. Epub 2022 Sep 21.
3
Risk factors for mortality in patients undergoing peritoneal dialysis: a systematic review and meta-analysis.腹膜透析患者死亡的风险因素:系统评价和荟萃分析。
Ren Fail. 2021 Dec;43(1):743-753. doi: 10.1080/0886022X.2021.1918558.
4
Age differences in associations of serum alkaline phosphatase and mortality among peritoneal dialysis patients.腹膜透析患者血清碱性磷酸酶与死亡率之间关联的年龄差异。
Chin Med J (Engl). 2019 Jan 20;132(2):232-236. doi: 10.1097/CM9.0000000000000019.
5
Elevated serum alkaline phosphatase and cardiovascular or all-cause mortality risk in dialysis patients: A meta-analysis.血清碱性磷酸酶升高与透析患者心血管或全因死亡风险:一项荟萃分析。
Sci Rep. 2017 Oct 16;7(1):13224. doi: 10.1038/s41598-017-13387-z.
6
Nitrogen-doped Carbon Dots Mediated Fluorescent on-off Assay for Rapid and Highly Sensitive Pyrophosphate and Alkaline Phosphatase Detection.氮掺杂碳点介导的荧光开启-关闭分析用于快速高灵敏检测焦磷酸根和碱性磷酸酶。
Sci Rep. 2017 Jul 19;7(1):5849. doi: 10.1038/s41598-017-06356-z.
7
Corrigendum: An association between time-varying serum alkaline phosphatase concentrations and mortality rate in patients undergoing peritoneal dialysis: a five-year cohort study.勘误:腹膜透析患者血清碱性磷酸酶浓度随时间变化与死亡率之间的关联:一项为期五年的队列研究。
Sci Rep. 2017 Apr 25;7:46383. doi: 10.1038/srep46383.

本文引用的文献

1
Alkaline phosphatase and mortality in patients on peritoneal dialysis.腹膜透析患者的碱性磷酸酶与死亡率
Clin J Am Soc Nephrol. 2014 Apr;9(4):771-8. doi: 10.2215/CJN.08280813. Epub 2014 Jan 23.
2
Comparative mortality-predictability using alkaline phosphatase and parathyroid hormone in patients on peritoneal dialysis and hemodialysis.使用碱性磷酸酶和甲状旁腺激素对腹膜透析和血液透析患者进行死亡率预测的比较
Perit Dial Int. 2014 Nov-Dec;34(7):732-48. doi: 10.3747/pdi.2013.00110. Epub 2014 Jan 2.
3
Relationship between alkaline phosphatase and all-cause mortality in peritoneal dialysis patients.腹膜透析患者碱性磷酸酶与全因死亡率的关系。
Adv Perit Dial. 2013;29:61-3.
4
Prognostic importance of serum alkaline phosphatase in CKD stages 3-4 in a clinical population.在临床人群中,CKD 3-4 期血清碱性磷酸酶的预后意义。
Am J Kidney Dis. 2013 Oct;62(4):703-10. doi: 10.1053/j.ajkd.2013.04.012. Epub 2013 Jun 12.
5
Serum phosphate and calcium should be primarily and consistently controlled in prevalent hemodialysis patients.对于长期透析患者,应首要且持续地控制血清磷和钙水平。
Ther Apher Dial. 2013 Apr;17(2):221-8. doi: 10.1111/1744-9987.12030.
6
Associations of serum skeletal alkaline phosphatase with elevated C-reactive protein and mortality.血清骨碱性磷酸酶与 C 反应蛋白升高及死亡率的关系。
Clin J Am Soc Nephrol. 2013 Jan;8(1):26-32. doi: 10.2215/CJN.12031111. Epub 2012 Nov 2.
7
Bone alkaline phosphatase and mortality in dialysis patients.骨碱性磷酸酶与透析患者的死亡率。
Clin J Am Soc Nephrol. 2011 Jul;6(7):1752-9. doi: 10.2215/CJN.10091110. Epub 2011 May 19.
8
Effect of bone mineral guideline target achievement on mortality in incident dialysis patients: an analysis of the United Kingdom Renal Registry.在新进入透析的患者中,达到骨矿物质指南目标对死亡率的影响:对英国肾脏注册处的分析。
Am J Kidney Dis. 2011 Mar;57(3):415-21. doi: 10.1053/j.ajkd.2010.08.037. Epub 2010 Dec 4.
9
Serum alkaline phosphatase and mortality in hemodialysis patients.血液透析患者的血清碱性磷酸酶与死亡率
Clin Nephrol. 2010 Aug;74(2):91-6. doi: 10.5414/cnp74091.
10
Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population.血清 iPTH、钙和磷与欧洲血液透析人群的死亡率风险。
Nephrol Dial Transplant. 2011 Jun;26(6):1948-55. doi: 10.1093/ndt/gfq219. Epub 2010 Apr 25.